NCT02404168View on ClinicalTrials.gov

BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 7, 2015

Primary Completion Date

January 18, 2016

Study Completion Date

April 6, 2016

Conditions
Epilepsy
Interventions
DRUG

lamotrigine (brand Lamictal)

an anti-epileptic drug (brand)

DRUG

lamotrigine (generic Teva)

an anti-epileptic drug (brand)

Trial Locations (1)

21201

University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT02404168 - BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients | Biotech Hunter | Biotech Hunter